Abalos Therapeutics
PrivateLast Round
Grant
Mar 18, 2024
Total Funding Raised
$51.31M
Company Overview
Abalos Therapeutics is a biotechnology company developing a novel anti-cancer approach that uses the unique immune stimulation of the arenavirus to provide the full breadth of the immune system's power specifically against cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abalos Therapeutics Comparables
Compare Abalos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TILT Biotherapeutics | 77% | |
| Candel Therapeutics, Inc. | 75% | |
| Replimune Group Inc. | 73% | |
Abalos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 18, 2024 | ||||
| Series A Extension | Oct 14, 2021 | ||||
| Series A | Oct 15, 2019 |
Key People
Founding team and executive leadership
Abalos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Series A Extension, Series A |
| NRW.Bank | Series A Extension, Series A |
| Hx Bio Ventures | Series A Extension |
| Boehringer Ingelheim Venture Fund | Series A Extension, Series A |
| Ventura BioMed Investors | Series A Extension |
| Gründerfonds Ruhr | Series A Extension, Series A |
| High-Tech Gründerfonds | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 4, 2025
Added Ventura BioMed, a biotechnology startup, as a customer.
Abalos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abalos Therapeutics's valuation, stock price, and market status.